WuXi AppTec Stock Price, News & Analysis (OTCMKTS:WUXAY) $12.00 +0.20 (+1.69%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$12.00▼$12.0050-Day Range$10.37▼$12.8552-Week Range$7.77▼$14.10Volume636 shsAverage Volume4,262 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest About WuXi AppTec Stock (OTCMKTS:WUXAY)WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXAY Stock News HeadlinesJuly 19, 2023 | msn.comWuXi Biologics Hatches New Baby With ADC Drug Unit IPOJuly 10, 2023 | finance.yahoo.comAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH PatientsNovember 29, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!May 26, 2023 | wsj.comWuXi AppTec Co. Ltd. ADRApril 25, 2023 | marketwatch.comWuXi AppTec Shares Slide After First-Quarter Softer Profit GrowthApril 10, 2023 | marketwatch.comPharmaceutical Testing and Analytical Services Market Insights-Industry Changing Aspects, New Technologies and Forecast to 2030April 7, 2023 | marketwatch.comA Closer Look at the Patient Derived Xenograft or PDX Models Market (2023 to 2030)-Opportunities and ChallengesApril 4, 2023 | marketwatch.comContract Research Organization (CRO) Market | 2023-2029November 29, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!March 29, 2023 | marketwatch.comViral Clearance Service Market Size and Forecast till 2031March 28, 2023 | marketwatch.comCell Banking Outsourcing Market: New Forecast Report 2029March 20, 2023 | finance.yahoo.comWuXi AppTec Reports Record Results in 2022March 18, 2023 | seekingalpha.comWUXAY WuXi AppTec Co., Ltd.See More Headlines Receive WUXAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:WUXAY CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone862120663091FaxN/AEmployees41,148Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 56)Co-Founder, Chairman, President & CEO Comp: $5.8MDr. Minzhang Chen Ph.D. (Age 53)Co-CEO & Executive Director Comp: $1.38MDr. Qing Yang Ph.D. (Age 54)Co-CEO & Executive Director Comp: $1.18MDr. Edward Hu M.B.A. (Age 60)Vice Chairman of the Board & Global Chief Investment Officer Comp: $1.47MMr. Zhaohui Zhang (Age 53)COO of China, VP & Executive Director Comp: $1.04MMs. Ming Shi (Age 48)Senior VP & CFO Mr. Kyler LeiIR DirectorDr. Howard Wu J.D.Senior VP, General Counsel & Global Head of Human ResourcesDr. Shuhui Chen Ph.D. (Age 59)Executive Vice President & Head of DDSU Dr. Jingchao Dong Ph.D.Senior VP & Head of RCSMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors WUXAY Stock Analysis - Frequently Asked Questions Should I buy or sell WuXi AppTec stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for WuXi AppTec in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" WUXAY shares. View WUXAY analyst ratings or view top-rated stocks. How have WUXAY shares performed in 2023? WuXi AppTec's stock was trading at $12.3570 at the start of the year. Since then, WUXAY shares have decreased by 2.9% and is now trading at $12.00. View the best growth stocks for 2023 here. How do I buy shares of WuXi AppTec? Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:WUXAY) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.